PMC:7189872 / 3562-4100 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"45","span":{"begin":464,"end":469},"obj":"Gene"},{"id":"46","span":{"begin":479,"end":484},"obj":"Gene"},{"id":"64","span":{"begin":116,"end":121},"obj":"Species"},{"id":"65","span":{"begin":393,"end":402},"obj":"Species"}],"attributes":[{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Gene:43740569"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Gene:43740573"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"Tax:9606"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":47,"end":51},"obj":"Body_part"},{"id":"T11","span":{"begin":499,"end":509},"obj":"Body_part"},{"id":"T12","span":{"begin":517,"end":538},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma82739"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma67858"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T14","span":{"begin":393,"end":397},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T31","span":{"begin":45,"end":51},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T32","span":{"begin":77,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T33","span":{"begin":116,"end":121},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T34","span":{"begin":223,"end":224},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T35","span":{"begin":352,"end":359},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T36","span":{"begin":428,"end":433},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T37","span":{"begin":493,"end":494},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":352,"end":359},"obj":"Chemical"},{"id":"T14","span":{"begin":499,"end":504},"obj":"Chemical"},{"id":"T15","span":{"begin":505,"end":509},"obj":"Chemical"},{"id":"T16","span":{"begin":531,"end":538},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":86,"end":101},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":24,"end":173},"obj":"Sentence"},{"id":"T29","span":{"begin":174,"end":297},"obj":"Sentence"},{"id":"T30","span":{"begin":298,"end":403},"obj":"Sentence"},{"id":"T31","span":{"begin":404,"end":478},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T62","span":{"begin":45,"end":51},"obj":"CL:0000084;BV_24"},{"id":"T63","span":{"begin":52,"end":60},"obj":"BV_24"},{"id":"T64","span":{"begin":86,"end":92},"obj":"UBERON:0002405;GO:0006955"},{"id":"T65","span":{"begin":93,"end":101},"obj":"GO:0006955"},{"id":"T66","span":{"begin":116,"end":121},"obj":"SP_6;NCBITaxon:9606"},{"id":"T67","span":{"begin":204,"end":212},"obj":"BV_9"},{"id":"T68","span":{"begin":393,"end":402},"obj":"SP_7"},{"id":"T69","span":{"begin":428,"end":433},"obj":"NCBITaxon:10239"},{"id":"T70","span":{"begin":479,"end":484},"obj":"SO:0000236"},{"id":"T71","span":{"begin":517,"end":530},"obj":"GO:0016020"},{"id":"T19283","span":{"begin":45,"end":51},"obj":"CL:0000084;BV_24"},{"id":"T21435","span":{"begin":52,"end":60},"obj":"BV_24"},{"id":"T85839","span":{"begin":86,"end":92},"obj":"UBERON:0002405;GO:0006955"},{"id":"T63617","span":{"begin":93,"end":101},"obj":"GO:0006955"},{"id":"T62297","span":{"begin":116,"end":121},"obj":"SP_6;NCBITaxon:9606"},{"id":"T14783","span":{"begin":204,"end":212},"obj":"BV_9"},{"id":"T54733","span":{"begin":393,"end":402},"obj":"SP_7"},{"id":"T21604","span":{"begin":428,"end":433},"obj":"NCBITaxon:10239"},{"id":"T11044","span":{"begin":479,"end":484},"obj":"SO:0000236"},{"id":"T31869","span":{"begin":517,"end":530},"obj":"GO:0016020"}],"text":"thods of wet labs [23]. We tried to identify T-cell epitopes that can elicit a robust immune response in the global human population and act as potential vaccine candidates. However, the ability of these epitopes to act as a vaccine candidate needs to be analyzed in Molecular biology lab studies. Our investigation can open new dimensions in crafting peptide-based vaccine regimens for Novel SARS-COV2. The greatest decline in virus expansion was noted following ORF3a removal. ORF7a encodes a 122-amino-acid type I transmembrane protein"}